Anti-inflammatory effects of epidermal growth factor on the immature human intestine

Physiological Genomics

Volumn 44, Issue 4, 2012, Pages 268-280

  Ménard, Daniel ^a   Tremblay, Eric ^a   Ferretti, Emanuela ^b   Babakissa, Corentin ^a   Perron, Nancy ^a   Seidman, Ernest G ^c   Levy, Emile ^d   Beaulieu, Jean François ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Colon; Gene expression; Microarrays; Midgestation; Small intestine

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; COLON; CONTROLLED STUDY; DATA ANALYSIS; ENTEROPATHY; EXPLANT; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ILEUM; NEWBORN DISEASE; NUCLEOTIDE SEQUENCE; ORGAN CULTURE TECHNIQUE; ORGANOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE MICROARRAY;

CHEMOKINE CCL2; CHEMOKINE CXCL10; CHEMOKINE CXCL5; CHEMOKINES, CC; COLON; EPIDERMAL GROWTH FACTOR; HUMANS; ILEUM; INTESTINES; ORGAN CULTURE TECHNIQUES;

EID: 84857769196     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00101.2011     Document Type: Article

References (82)

1. Abou-Rjaily GA, Lee SJ, May D, Al-Share QY, Deangelis AM, Ruch RJ, Neumaier M, Kalthoff H, Lin SH, Najjar SM. CEACAM1 modulates epidermal growth factor receptor-mediated cell proliferation. J Clin Invest 114: 944-952, 2004.
2. Amin HJ, Zamora SA, McMillan DD, Fick GH, Butzner JD, Parsons HG, Scott RB. Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr 140: 425-431, 2002.
3. Arsenault P, Menard D. Cell proliferation during morphogenesis of the human colon. Biol Neonate 55: 137-142, 1989.
4. Arsenault P, Menard D. Cell proliferation in developing human jejunum. Biol Neonate 51: 297-304, 1987.
5. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 199: 28-35, 2003.
6. Basora N, Herring-Gillam FE, Boudreau F, Perreault N, Pageot LP, Simoneau M, Bouatrouss Y, Beaulieu JF. Expression of functionally distinct variants of the beta(4)A integrin subunit in relation to the differentiation state in human intestinal cells. J Biol Chem 274: 29819-29825, 1999.
7. Beaulieu JF, Calvert R. The effect of epidermal growth factor (EGF) on the differentiation of the rough endoplasmic reticulum in fetal mouse small intestine in organ culture. J Histochem Cytochem 29: 765-770, 1981.
8. Beaulieu JF, Menard D, Calvert R. Influence of epidermal growth factor on the maturation of the fetal mouse duodenum in organ culture. J Pediatr Gastroenterol Nutr 4: 476-481, 1985.
9. Beaulieu JF, Nichols B, Quaroni A. Posttranslational regulation of sucrase-isomaltase expression in intestinal crypt and villus cells. J Biol Chem 264: 20000-20011, 1989.
10. Beaulieu JF, Quaroni A. Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma Caco-2 cells. Biochem J 280: 599-608, 1991.
11. Beaulieu JF, Vachon PH. Reciprocal expression of laminin A-chain isoforms along the crypt-villus axis in the human small intestine. Gastroenterology 106: 829-839, 1994.
12. Caicedo RA, Schanler RJ, Li N, Neu J. The developing intestinal ecosystem: implications for the neonate. Pediatr Res 58: 625-628, 2005.
13. Caplan M. Is EGF the Holy Grail for NEC? J Pediatr 150: 329-330, 2007.
14. Clark JA, Doelle SM, Halpern MD, Saunders TA, Holubec H, Dvorak K, Boitano SA, Dvorak B. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 291: G938-G949, 2006.
15. Clark JA, Lane RH, Maclennan NK, Holubec H, Dvorakova K, Halpern MD, Williams CS, Payne CM, Dvorak B. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 288: G755-G762, 2005.
16. Claud EC, Walker WA. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J 15: 1398-1403, 2001.
17. Di Lorenzo M, Bass J, Krantis A. Use of L-arginine in the treatment of experimental necrotizing enterocolitis. J Pediatr Surg 30: 235-240, 1995.
18. Drumm B, Cutz E, Tomkins KB, Cook D, Hamilton JR, Sherman P. Urogastrone/epidermal growth factor in treatment of congenital microvillous atrophy. Lancet 1: 111-112, 1988.
19. Dvorak B. Milk epidermal growth factor and gut protection. J Pediatr 156: S31-S35, 2010.
20. Dwinell MB, Lugering N, Eckmann L, Kagnoff MF. Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology 120: 49-59, 2001.
21. Dydensborg AB, Herring E, Auclair J, Tremblay E, Beaulieu JF. Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. Am J Physiol Gastrointest Liver Physiol 290: G1067-G1074, 2006.
22. Fell JM. Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis. Early Hum Dev 81: 117-122, 2005.
23. FitzGerald AJ, Pu M, Marchbank T, Westley BR, May FE, Boyle J, Yadollahi-Farsani M, Ghosh S, Playford RJ. Synergistic effects of systemic trefoil factor family 1 (TFF1) peptide and epidermal growth factor in a rat model of colitis. Peptides 25: 793-801, 2004.
24. Francoeur C, Bouatrouss Y, Seltana A, Pinchuk IV, Vachon PH, Powell DW, Sawan B, Seidman EG, Beaulieu JF. Degeneration of the pericryptal myofibroblast sheath by proinflammatory cytokines in inflammatory bowel diseases. Gastroenterology 136: 268-277, 2009.
25. Halpern MD, Dominguez JA, Dvorakova K, Holubec H, Williams CS, Meza YG, Ruth MC, Dvorak B. Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor. J Pediatr Gastroenterol Nutr 36: 126-133, 2003.
26. Henry MC, Moss RL. Necrotizing enterocolitis. Annu Rev Med 60: 111-124, 2009.
27. Hoehn T, Stover B, Buhrer C. Colonic pneumatosis intestinalis in preterm infants: different to necrotising enterocolitis with a more benign course? Eur J Pediatr 160: 369-371, 2001.
28. Keates S, Keates AC, Mizoguchi E, Bhan A, Kelly CP. Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 273: G75-G82, 1997.
29. Kliegman RM. The relationship of neonatal feeding practices and the pathogenesis and prevention of necrotizing enterocolitis. Pediatrics 111: 671-672, 2003.
30. Leonidas JC, Hall RT. Neonatal pneumatosis coli: a mild form of neonatal necrotizing enterocolitis. J Pediatr 89: 456-459, 1976.
31. Levy E, Delvin E, Menard D, Beaulieu JF. Functional development of human fetal gastrointestinal tract. Methods Mol Biol 550: 205-224, 2009.
32. Mascia F, Mariani V, Girolomoni G, Pastore S. Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol 163: 303-312, 2003.
33. Maynard AA, Dvorak K, Khailova L, Dobrenen H, Arganbright KM, Halpern MD, Kurundkar AR, Maheshwari A, Dvorak B. Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 299: G614-G622, 2010.
34. McCormack G, Moriarty D, O'Donoghue DP, McCormick PA, Sheahan K, Baird AW. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 50: 491-495, 2001.
35. McMellen ME, Wakeman D, Erwin CR, Guo J, Warner BW. Epidermal growth factor receptor signaling modulates chemokine (CXC) ligand 5 expression and is associated with villus angiogenesis after small bowel resection. Surgery 148: 364-370, 2010.
36. Menard D. Functional development of the human gastrointestinal tract: hormone- and growth factor-mediated regulatory mechanisms. Can J Gastroenterol 18: 39-44, 2004.
37. Ménard D. Growth-promoting factors and the development of the humangut. In: Human Intestinal Development, edited by Lebenthal E. New-York: Raven Press, 1989, p. 123-150.
38. Menard D, Arsenault P. Explant culture of human fetal small intestine. Gastroenterology 88: 691-700, 1985.
39. Menard D, Arsenault P. Human fetal colon in organ culture. Anat Embryol (Berl) 176: 441-448, 1987.
40. Menard D, Arsenault P, Pothier P. Biologic effects of epidermal growth factor in human fetal jejunum. Gastroenterology 94: 656-663, 1988.
41. Ménard D, Beaulieu JF. Human intestinal brush border membrane hydrolases. In: Membrane Physiopathology, edited by Bkaily G. Norwell: Kluweer Academic Publisher, 1994, p. 319-341.
42. Ménard D, Beaulieu JF, Boudreau F, Perreault N, Rivard N, Vachon Gastrointestinal tract PH. In: Cell Signaling and Growth Factors in Development: From molecules to Organogenesis, edited by Unsicker K and Krieglstein K. Weinheim: Wiley-Vch., 2006, p. 755-790.
43. Menard D, Corriveau L, Arsenault P. Differential effects of epidermal growth factor and hydrocortisone in human fetal colon. J Pediatr Gastroenterol Nutr 10: 13-20, 1990.
44. Menard D, Pothier P. Differential distribution of digestive enzymes in isolated epithelial cells from developing human fetal small intestine and colon. J Pediatr Gastroenterol Nutr 6: 509-516, 1987.
45. Menard D, Pothier P. Radioautographic localization of epidermal growth factor receptors in human fetal gut. Gastroenterology 101: 640-649, 1991.
46. Montgomery RK, Mulberg AE, Grand RJ. Development of the human gastrointestinal tract: twenty years of progress. Gastroenterology 116: 702-731, 1999.
47. Nagaishi T, Chen Z, Chen L, Iijima H, Nakajima A, Blumberg RS. CEACAM1 and the regulation of mucosal inflammation. Mucosal Immunol 1, Suppl 1: S39-S42, 2008.
48. Nair RR, Warner BB, Warner BW. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis. Semin Perinatol 32: 107-113, 2008.
49. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 97: 6043-6048, 2000.
50. Nanthakumar NN, Young C, Ko JS, Meng D, Chen J, Buie T, Walker WA. Glucocorticoid responsiveness in developing human intestine: possible role in prevention of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 288: G85-G92, 2005.
51. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 364: 255-264, 2011.
52. Oikonomou KA, Kapsoritakis AN, Kapsoritaki AI, Manolakis AC, Tsiopoulos FD, Germenis AE, Potamianos SP. Downregulation of serum epidermal growth factor in patients with inflammatory bowel disease. Is there a link with mucosal damage? Growth Factors 28: 461-466, 2010.
53. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
54. Pothier P, Menard D. Presence and characteristics of epidermal growth factor receptors in human fetal small intestine and colon. FEBS Lett 228: 113-117, 1988.
55. Puleston J, Cooper M, Murch S, Bid K, Makh S, Ashwood P, Bingham AH, Green H, Moss P, Dhillon A, Morris R, Strobel S, Gelinas R, Pounder RE, Platt A. A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther 21: 109-120, 2005.
56. Raul F, Lacroix B, Aprahamian M. Longitudinal distribution of brush border hydrolases and morphological maturation in the intestine of the preterm infant. Early Hum Dev 13: 225-234, 1986.
57. Roda G, Dahan S, Mezzanotte L, Caponi A, Roth-Walter F, Pinn D, Mayer L. Defect in CEACAM family member expression in Crohn's disease IECs is regulated by the transcription factor SOX9. Inflamm Bowel Dis 15: 1775-1783, 2009.
58. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378, 2003.
59. Schaart MW, de Bruijn AC, Bouwman DM, de Krijger RR, van Goudoever JB, Tibboel D, Renes IB. Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants. J Pediatr Gastroenterol Nutr 49: 31-41, 2009.
60. Scheerens H, Hessel E, de Waal-Malefyt R, Leach MW, Rennick D. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells. Eur J Immunol 31: 1465-1474, 2001.
61. Schroepf S, Kappler R, Brand S, Prell C, Lohse P, Glas J, Hoster E, Helmbrecht J, Ballauff A, Berger M, von Schweinitz D, Koletzko S, Lacher M. Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease. Inflamm Bowel Dis 16: 1882-1890, 2010.
62. Sebastio G, Hunziker W, O'Neill B, Malo C, Menard D, Auricchio S, Semenza G. The biosynthesis of intestinal sucrase-isomaltase in human embryo is most likely controlled at the level of transcription. Biochem Biophys Res Commun 149: 830-839, 1987.
63. Sham J, Martin G, Meddings JB, Sigalet DL. Epidermal growth factor improves nutritional outcome in a rat model of short bowel syndrome. J Pediatr Surg 37: 765-769, 2002.
64. Sigalet DL, Martin GR, Butzner JD, Buret A, Meddings JB. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. J Pediatr Surg 40: 763-768, 2005.
65. Simoneau A, Herring-Gillam FE, Vachon PH, Perreault N, Basora N, Bouatrouss Y, Pageot LP, Zhou J, Beaulieu JF. Identification, distribution,and tissular origin of the alpha5(IV) and alpha6(IV) collagen chains in the developing human intestine. Dev Dyn 212: 437-447, 1998.
66. Singh UP, Venkataraman C, Singh R, Lillard JW Jr. CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocr Metab Immune Disord Drug Targets 7: 111-123, 2007.
67. Streeter G. Weight, sitting head, head size, foot length, and menstrual age of the human embryo. Contr Embryol 11: 143-179, 1920.
68. Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 16: 593-609, 2005.
69. Sullivan PB, Lewindon PJ, Cheng C, Lenehan PF, Kuo BS, Haskins JR, Goodlad RA, Wright NA, de la Iglesia FA. Intestinal mucosa remodeling by recombinant human epidermal growth factor(1-48) in neonates with severe necrotizing enterocolitis. J Pediatr Surg 42: 462-469, 2007.
70. Sun FF, Lai PS, Yue G, Yin K, Nagele RG, Tong DM, Krzesicki RF, Chin JE, Wong PY. Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation 25: 33-45, 2001.
71. Suzuki K, Kawauchi Y, Palaniyandi SS, Veeraveedu PT, Fujii M, Yamagiwa S, Yoneyama H, Han GD, Kawachi H, Okada Y, Ajioka Y, Watanabe K, Hosono M, Asakura H, Aoyagi Y, Narumi S. Blockade of interferon-gamma-inducible protein-10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells. Pathol Int 57: 413-420, 2007.
72. Teller IC, Auclair J, Herring E, Gauthier R, Menard D, Beaulieu JF. Laminins in the developing and adult human small intestine: relation with the functional absorptive unit. Dev Dyn 236: 1980-1990, 2007.
73. Travadi JN, Patole SK, Gardiner K. Pneumatosis coli, a benign form of necrotising enterocolitis. Indian Pediatr 40: 349-351, 2003.
74. Tremblay E, Auclair J, Delvin E, Levy E, Menard D, Pshezhetsky AV, Rivard N, Seidman EG, Sinnett D, Vachon PH, Beaulieu JF. Gene expression profiles of normal proliferating and differentiating human intestinal epithelial cells: a comparison with the Caco-2 cell model. J Cell Biochem 99: 1175-1186, 2006.
75. Tremblay E, Ferretti E, Babakissa C, Seidman EG, Levy E, Menard D, Beaulieu JF. Gene-expression profile analysis in the mid-gestation human intestine discloses greater functional immaturity of the colon as compared with the ileum. J Pediatr Gastroenterol Nutr 52: 670-678, 2011.
76. Villablanca EJ, Cassani B, von Andrian UH, Mora JR. Blocking lymphocyte localization to the gastrointestinal mucosa as a therapeutic strategy for inflammatory bowel diseases. Gastroenterology 140: 1776-1784, 2011.
77. Walker-Smith JA, Phillips AD, Walford N, Gregory H, Fitzgerald JD, MacCullagh K, Wright NA. Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophy. Lancet 2: 1239-1240, 1985.
78. Warner BW, Erwin CR. Critical roles for EGF receptor signaling during resection-induced intestinal adaptation. J Pediatr Gastroenterol Nutr 43, Suppl 1: S68-S73, 2006.
79. Wermers JD, McNamee EN, Wurbel MA, Jedlicka P, Rivera-Nieves J. The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice. Gastroenterology 140: 1526-1535, 2011.
80. Wurbel MA, McIntire MG, Dwyer P, Fiebiger E. CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis. PLoS One 6: e16442, 2011.
81. Young CM, Kingma SD, Neu J. Ischemia-reperfusion and neonatal intestinal injury. J Pediatr 158: e25-e28, 2011.
82. Z'Graggen K, Walz A, Mazzucchelli L, Strieter RM, Mueller C. The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology 113: 808-816, 1997.